TY  - GEN
AU  - Luster,Troy A
AU  - Carrell,Jeffrey A
AU  - McCormick,Kathy
AU  - Sun,David
AU  - Humphreys,Robin
TI  - Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib
SN  - 1535-7163
PY  - 2009///0324
KW  - Antibodies
KW  - pharmacology
KW  - Antibodies, Monoclonal
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Apoptosis
KW  - drug effects
KW  - Boronic Acids
KW  - Bortezomib
KW  - Carcinoma, Non-Small-Cell Lung
KW  - enzymology
KW  - Caspases
KW  - metabolism
KW  - Cell Death
KW  - Cell Line, Tumor
KW  - Death Domain Receptor Signaling Adaptor Proteins
KW  - Drug Resistance, Neoplasm
KW  - Drug Screening Assays, Antitumor
KW  - Drug Synergism
KW  - Enzyme Activation
KW  - Humans
KW  - Lung Neoplasms
KW  - Pyrazines
KW  - Receptors, TNF-Related Apoptosis-Inducing Ligand
KW  - immunology
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1158/1535-7163.MCT-08-0918
ER  -